This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oliver, R. The clinical potential of interleukin-2. Br J Cancer 58, 405–409 (1988). https://doi.org/10.1038/bjc.1988.230
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.230
This article is cited by
-
Elimination of CD4+ T cells in mice bearing an advanced sarcoma augments the antitumor action of interleukin-2
Cancer Immunology Immunotherapy (1994)
-
Treatment of chemically induced autochthonous rat mammary and colorectal carcinomas with interleukin-2
Cancer Immunology Immunotherapy (1991)